Why the study?
Do ATP2B1 rs2681472 and STK39 rs35929607 polymorphisms increase the risk of essential hypertension in an Iranian population?
Do ATP2B1 rs2681472 and STK39 rs35929607 polymorphisms increase the risk of essential hypertension in an Iranian population?
ATP2B1 rs2681472 and STK39 rs35929607 polymorphisms do not appear to have a significant effect on the risk of essential hypertension in the Iranian population.
These variants should not inform hypertension risk assessment in Iranians; leaves open validation in larger, multi-ethnic cohorts.
Our study indicated that rs2681472 of ATP2B1 and rs35929607 of STK39 may not have a significant effect on the risk of essential hypertension in Iranian population. More studies are still needed to validate our results.
No takes yet. Share an insight, caveat, or question.
Jamshidi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: